Latest filing published 19 Aug 2026 for 티앤알바이오팹. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
윤원수, listed as chief executive, appears in our data through filings on 티앤알바이오팹 shares, published by DART (FSS). The record holds 51 filings, for trades running from 12 March 2021 to 19 August 2026.
Both buying and selling appear: 7 purchases worth €102k, against 3 sales. The amount is not disclosed for 9 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 3 purchases and 3 sales.
Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 19 August 2026, the filings show a transaction in 티앤알바이오팹. The latest purchase dates back some time: it was published 181 days ago, on 20 April 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. Until a filing is published, the market cannot know about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 51 declarations